A simulation environment for the sport of boxing utilizing a robotic machine interface system which carries a person.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8163720 | Pyrrolidinyl phenyl sulphonamides as modulators of ion channels The present invention relates to phenyl sulfonamides useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of variou... | 04/24/2012 |
| 7232811 | Furosemide modulators of HM74 Host cells expressing HM74 were used to obtain furosemide-like molecules with agonist activity having the following structure formula: ... | 06/19/2007 |
| 6518274 | Use of cyclopentabenzofuran-derivatives for combating (NF-.kappa.B)-dependent diseases The invention relates to the use of cycloventabenzofuran derivatives for the production of a medicament for the treatment of nuclear factor of .kappa.B-dependent diseases.... | 02/11/2003 |
| 6306842 | Protected forms of a combination of pharmacologically active agents and uses therefor In accordance with the present invention, there are provided conjugates of a combination of pharmacologically active agents (e.g., NSAIDs and selective COX-2 inhibitors). Invention conjugates provide a new class of pharmacologically active agents (e.g., a... | 10/23/2001 |
| 6284752 | Pharmaceutical compositions comprising metal complexes New pharmaceutical compositions and pharmaceutical compositions comprising metal complexes have activity against diseases caused by or related to overproduction or localised high concentration of nitric oxide in the body.... | 09/04/2001 |
| 6262040 | Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF) The invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R, R1, and R2, are as defined herein. The invention further relates to pharmaceutical compositions containing, and methods of us... | 07/17/2001 |
| 6004948 | Derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase II Compounds of the formula (I) in which A is oxygen, sulphur or NH; B is a group of the formula (IIa) or (IIb); and the other variables have the meaning given in claim 1, may be used as inhibitors of the enzyme cyclooxygenase II ##STR1##... | 12/21/1999 |
| 5958910 | Use of N-(4-aryl-thiazol-2-yl)-sulfonamides The invention is concerned with the use of sulfonamide derivatives of the general formula ##STR1## wherein R Signifies lower-alkyl, phenyl, benzyl, naphthyl, pyridyl or thienyl, optionally substituted by one or more lower-alkyl, lower-alkoxy, lo... | 09/28/1999 |
| 5753688 | Substituted pyrazolyl benzenesulfonamides for the treatment of gastrointestinal conditions A class of pyrazolyl benzenesulfonamide compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula I: ##STR1## or a pharmaceutically-acceptable salt thereof.... | 05/19/1998 |
| 5547975 | Benzopyranopyrazolyl derivatives for the treatment of inflammation A class of benzopyranopyrazolyl derivatives is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula I ##STR1## wherein A is --(CH2)m --X--(CH... | 08/20/1996 |
| 5516010 | Sanitary speculum for tympanic thermometer probe A sanitary protective cover or sheath for the ear canal probe of a tympanic thermometer. The speculum has a generally tubular body portion and an infrared transparent membrane attached to and sealing the forward end of the body portion. While the tubular ... | 05/14/1996 |
| 5273970 | Treatment of protozoal diseases The antibacterial substance baquiloprim (2,4-diamino-5-[8-dimethylamino-7-methyl-5-quinolylmethyl]pyrimidine) is shown to be active against protozoal infections, e.g. toxoplasmosis. Preferably the baquiloprim is administered together with a sulphonamide.... | 12/28/1993 |
| 5258374 | Method of treatment of allergic conjuctivitis Furosemide ##STR1## is used as medicament for the treatment of allergic conjunctivitis; it is dropped into the conjunctival fornix of the eye.... | 11/02/1993 |
| 5135924 | Therapeutic treatment of animals with oral administration of ormetoprim-potentiated sulfonamides Systemic bacterial infections caused by aerobic and anaerobic organisms in companion animals such as dogs can be treated effectively and conveniently by the oral administration on a once a day basis of an antibacterial combination of ormetoprim and a sulf... | 08/04/1992 |
| 5096897 | Antithrombotic substituted cycloalkano(b)dihydroindole- and -indole-sulphonamides Substituted antithrombotic substituted cycloalkano[b]-dihydroindole- and -indole-sulphonamides for treatment of thromboses, thromboembolisms, ischaemias, asthma and allergies, of the formula ##STR1## in which R1, R2, R3 | 03/17/1992 |
| 5039670 | Antithrombotic substituted cycloalkano(B)dihydroindole- and -indole-sulphonamides and use Substituted antithrombotic substituted cycloalkano[b]-dihydroindole- and -indole-sulphonamides for treatment of thromboses, thromboembolisms, ischemias, asthma and allergies, of the formula ##STR1## in which R1, R2, R3 | 08/13/1991 |
| 5037822 | 1-arylsulphonyl-2-pyrrolidinethione or 1-arylsulphonyl-2-piperidinethione derivatives, process for the preparation thereof their application as medicinal products and compositions containing them The invention relates to the products of formula ##STR1## in which R represents the radical ##STR2## in which R1 at any position on the benzene ring represents a linear, branched or cyclic alkyl, alkenyl or alkynyl containing up to 8 ... | 08/06/1991 |
| 4985417 | Treatment of glaucoma Method and formulation useful in treatment of glaucoma in a mammal wherein an effective amount of an active water soluble carbonic anhydrase inhibitor is administered, said inhibitor being a compound having the formula ##STR1## or a pharmaceutic... | 01/15/1991 |
| 4981873 | Substituted sulphonamides, pharmaceuticals thereof and methods of using them The present invention concerns compounds of the formula: ##STR1## where R1 is an alkyl or alkenyl radical containing up to 6 carbon atoms, a cycloalkyl radical containing 3 to 7 carbon atoms, an aralkyl, aralkenyl or aryl radical in which ... | 01/01/1991 |
| 4971989 | Substituted 1-arylpyrazoles, pesticidal compositions and use Substituted 1-arylpyrazoles useful in combating insects having the arachnida and nematodes of the formula ##STR1## in which R1 represents hydrogen or alkyl, R2 represents alkyl or halogenoalkyl, R3 represents hydrogen or a... | 11/20/1990 |
| 4965258 | Cycloalkano(1,2-B)indole-sulphonamides, pharmaceutical compositions and use Cycloalkano[1,2-b]indole-sulphonamides of the formula ##STR1## where appropriate in an isomeric form, and their salts are disclosed. These compounds are useful to inhibit platelet aggregation and to antoganize thromboxane A2.... | 10/23/1990 |
| 4960774 | Cyclic amines and fungicides containing them Amines of the general formula I ##STR1## where n is an integer from 2 to 10, X is oxygen or sulfur, Z is oxygen or CH--R5, and R1, R2, R3, R4 and R5 are identical or different and are ... | 10/02/1990 |
| 4954486 | Furosemide as tinnitus suppressant Tinnitus symptoms were treated with furosemide, a loop diuretic, and reductions in tinnitus symptoms were observed.... | 09/04/1990 |
| 4888327 | Topical antibiotic compositions Disclosed are antibiotic compositions for topical administration comprising an aminoglycoside, a benzylpyrimidine and a sulfonamide.... | 12/19/1989 |
| 4833132 | Process for treating a warm-blooded animal with an antineoplastic/antime-tastatic effective composition There is disclosed a process for treating a warm-blooded animal wherein there is administered to the warm-blooded animal a therapeutically effective amount of composition selected from the group consisting of 5-methyl-3-sulfanilamidoisoxazole, a salt of ... | 05/23/1989 |
| 4818753 | Synthesis and method of use for 2, 4 diaminoquinazoline Compounds of the formula ##STR1## wherein R1 is H, methyl, ethyl, or chloro and R2 is hydrocarbyl of 1-12 C are useful as antifungal agents. Compounds of this series wherein R2 is 7-12 C are novel. A new synthetic met... | 04/04/1989 |
| 4781920 | Anthelmintic paste compositions containing resinates of d1-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole The invention provides physically stable anthelmintic paste compositions containing resinates of d1-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole and other anthelmintic compounds in combination with a wide variety of therapeutic agents such as an... | 11/01/1988 |
| 4769236 | Medicaments with a high degree of solubility and method for their production The present invention relates to medicaments with a high degree of dissolution rate and solubility. These medicaments are characterized in that they are in amorphous form produced by spraying in the presence of a stabilizer and of an agent inhibiting the ... | 09/06/1988 |
| 4735959 | Carboxylic acid amides and pharmaceutical compositions containing them There are described novel carboxylic acid derivatives of the formula ##STR1## and derivatives of the formula ##STR2## and the addition salts thereof, which exhibit an effect on the intermediary metabolism. Furthermore, the compounds of Formula I... | 04/05/1988 |
| 4711777 | Pharmaceutical tablets Novel tablets comprising (a) 80 to 98% by weight of a mixture of trimethoprim and/or an acid addition salt thereof and a sulfonamide and/or a salt thereof in a weight ratio of 1:20 to 20:1 and (b) a pharmaceutically acceptable synthetic ion exchange resin... | 12/08/1987 |
| 4708952 | Method of treatment of the infectious and viral diseases by one time interference A composition adapted to prolong the residence time of sulfa and cinchona alkaloid drugs in the circulating plasma of mammals including humans comprising hexanoic acid, potassium hydrogen tartrate, tannic acid, pectin and riboflavin, with the further pres... | 11/24/1987 |
| 4698335 | Process for treating a warm-blooded animal to be subjected to radiotherapy There is disclosed a process for treating a warm-blooded animal to be subjected to radiotherapy or chemotherapy wherein there is administered to the warm-blooded animal a therapeutically effective amount of a composition selected from the group consisting... | 10/06/1987 |
| 4661478 | Process for potentiating effects of barbituate anesthesia to a warm-blooded animal There is disclosed a process for treating a warm-blooded animal subjected to barbituate anesthesia to potentiate effects thereof wherein there is administered to the warm-blooded animal a therapeutically effective amount of a composition selected from the... | 04/28/1987 |
| 4632919 | Process for prolonging recalcification, prothrombin and thrombin times of plasma There is disclosed a process for prolonging recalcification, prothrombin and thrombin times of human plasma which comprises administering to a warm-blooded animal a composition selected from the group consisting of 5-methyl-3-sulfanilamidoisoxazole, a sal... | 12/30/1986 |
| 4632920 | Process for treating a warm-blooded animal following burn injury There is disclosed a process for treating a warm-blooded animal following burn injury wherein there is administered to the warm-blooded animal a therapeutically effect amount of a composition selected from the group consisting of 5-methyl-3-sulfanilamidoi... | 12/30/1986 |
| 4610981 | N-[(1H-imidazol-1-yl) and (1H-1,2,4-triazol-1-yl)-alkyl]benzenesulfonamides and thromboxane synthetase/antihypertensive compositions This invention concerns novel N-[(1H-imidazol-1-yl), (1H-1,2,4-triazol-1-yl) and (3-pyridyl)alkyl]benzenesulfonamides which are useful as inhibitors of thromboxane synthetase enzyme and/or as antihypertensive agents.... | 09/09/1986 |
| 4551464 | Antithrombotic sulfoximino carbostyrils Compounds of the formula ##STR1## wherein n is 0 or 1; A is methylene, vinylene or ethylene optionally substituted by lower alkyl; B is alkylene; R1 is an optionally substituted alkyl, phenyl or naphthyl group, or a cycloalkyl or pyridyl group;... | 11/05/1985 |
| 4478822 | Drug delivery system utilizing thermosetting gels This invention relates to a unique drug delivery system for delivering drugs to a body cavity. The drug delivery system comprises a medicament and a polymer such that the drug delivery system is a liquid at room temperature but forms a semi-solid or gel a... | 10/23/1984 |
| 4474753 | Topical drug delivery system utilizing thermosetting gels This invention relates to a unique drug delivery system for application to the skin which drug delivery system is a liquid at room temperature, but when administered topically to the skin becomes a semi-solid or gel when warmed by the body.... | 10/02/1984 |
| 4461765 | Suppository containing sulfamethoxazole/trimethoprim complex and process for preparing the same Suppository containing a one-to-one complex of sulfamethoxazole and trimethoprim dispersed in a pharmaceutically acceptable carrier is disclosed. It may contain a supplemental amount of sulfamethoxazole in addition to the sulfamethoxazole component in the... | 07/24/1984 |